Gastrointestinal side effects, including nausea, vomiting, diarrhea, and constipation, are common with GLP-1 receptor agonists
Practitioners may recommend DIM to support subcutaneous bio-identical hormone replacement therapy, increase sex drive, lower the risk of estrogen sensitive cancers (breast and prostate), reduce body fat and ease the symptoms of PMS and menopause
urgent medical attention is needed for severe abdominal pain, injection-site infection, irregular heartbeat, or hypoglycaemia symptoms
These arent the same as patient assistance programs
The relationship between mast cells, histamine, and the nervous system is a bidirectional vicious cycle
Oral vs injectable tirzepatide cost and insurance differences Injectable tirzepatide is expensive, but structured